MoonLake Immunotherapeuti Company Insiders

MoonLake Immunotherapeuti Management Team Effectiveness

The company has return on total asset (ROA) of (0.1332) % which means that it has lost $0.1332 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.168) %, meaning that it created substantial loss on money invested by shareholders. MoonLake Immunotherapeuti's management efficiency ratios could be used to measure how well MoonLake Immunotherapeuti manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.07 in 2024. Return On Capital Employed is likely to rise to -0.1 in 2024. At this time, MoonLake Immunotherapeuti's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 2.2 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 11.8 M in 2024. Common Stock Shares Outstanding is likely to drop to about 27.8 M in 2024. Net Loss is likely to rise to about (42.7 M) in 2024

MoonLake Immunotherapeuti Workforce Comparison

MoonLake Immunotherapeuti Insider Trading

MoonLake Immunotherapeuti Notable Stakeholders

The success or failure of an entity such as MoonLake Immunotherapeuti often depends on how effective the management is. MoonLake Immunotherapeuti management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MoonLake management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MoonLake management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in MoonLake Immunotherapeuti's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MoonLake Immunotherapeutics. Check MoonLake Immunotherapeuti's Beneish M Score to see the likelihood of MoonLake Immunotherapeuti's management manipulating its earnings.

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.